Use of immunomodulatory protein of ganoderma and recombinant thereof in treating brain tumor

TWI940747BActive Publication Date: 2026-10-01NAT YANG MING CHIAO TUNG UNIV
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
TW112100287
Authority / Receiving Office
TW · TW
Patent Type
Patents
Current Assignee / Owner
Filing Date
2023-01-04
Publication Date
2026-10-01
Estimated Expiration
2043-01-03

Smart Images

  • Figure TWG2TB001913377_001
    Figure TWG2TB001913377_001
  • Figure TWG2TB001913377_002
    Figure TWG2TB001913377_002
  • Figure TWG2TB001913377_003
    Figure TWG2TB001913377_003
Patent Text Reader

Abstract

A method for the prevention and treatment of brain tumors in individuals in need, particularly for refractory brain tumors, glioblastoma multiforme (GBM), or refractory GBM, is provided, including administering an effective amount of Ganoderma immunomodulatory protein, its recombinant form, or a fungal immunomodulatory protein with a similar structure to the individual.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Use of immunomodulatory protein from ganoderma in inhibiting cancer stem cells

    US20160184389A1

  • Methods and compositions for treating c-met associated cancers

    US20170368119A1